title: PCSK9 inhibition in type 2 diabetes: so far so good, but not there yet.
authors: Lipid Clinic Heart Institute (InCor), University of São Paulo Medical School Hospital and Preventive Medicine Centre and Cardiology Program, Hospital Israelita Albert Einstein, São Paulo, SP 05403, Brazil. Electronic address: raul.santos@incor.usp.br.
authors: Raul D
authors: RD
authors: Santos
mesh_terms: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003924:Diabetes Mellitus, Type 2; D006801:Humans; D008055:Lipids; D000071449:Proprotein Convertase 9
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D008055:Lipids; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9; C577155:evolocumab